HC Wainwright & Co. Maintains Buy on ASLAN Pharma, Lowers Price Target to $9

Benzinga · 03/18 11:04
HC Wainwright & Co. analyst Yi Chen maintains ASLAN Pharma (NASDAQ:ASLN) with a Buy and lowers the price target from $17 to $9.